Gainers
Virpax Pharmaceuticals, Inc. (NASDAQ: VRPX) shares surged 265.5% to close at $15.35 on Tuesday after the company received a written pre-investigational new drug (pre-IND) response from the FDA regarding MMS019.
This unusual options alert can help traders track potentially big trading opportunities. Traders often look for circumstances when the market estimation of an option diverges away from its normal worth. Unusual trading activity could push option prices to hyperbolic or underperforming levels.
Gainers
Virpax Pharmaceuticals, Inc. (NASDAQ: VRPX) shares jumped 93% to $$8.10 after the company received a written pre-investigational new drug (pre-IND) response from the FDA regarding MMS019.
Sea Ltd (NYSE: SE) is trading higher Tuesday after the company announced better-than-expected second-quarter financial results and raised its full-year 2021 guidance.
Shares of Sea (NYSE:SE) rose 6.0% in pre-market trading after the company reported Q2 results.
Quarterly Results
Earnings per share increased 10.29% year over year to ($0.61), which missed the estimate of ($0.52).
Raising Guidance
We are raising the guidance for both digital entertainment and e-commerce for the full year of 2021.
We expect bookings for digital entertainment to be between US$4.5 billion and US$4.7